Work

Abstract 6466: Preliminary results of a phase 2 study of leronlimab in combination with TAS-102 and bevacizumab in previously treated metastatic colorectal cancer

Year: 2026

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.am2026-6466

Authors: Pashtoon M. Kasi, Ari Baron, Arvind Chaudhry, Laura Tenner, Daniel L. Adams, Alexis B. Duffy, Hallgeir Rui, Patrick Vittner, Joseph Meidling, Jacob P. Lalezari

Institutions: City Of Hope National Medical Center, California Pacific Medical Center, Nebraska Medical Center, Fred and Pamela Buffett Cancer Center, University of Nebraska Medical Center, Creatv MicroTech (United States), Thomas Jefferson University, CytoDyn Inc. (United States)

Language: English

Topic: Colorectal Cancer Treatments and Studies

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7148701250

Cites:

Cited by: 1

Related to: